165 related articles for article (PubMed ID: 7603536)
1. Heteroplasmic mitochondrial tRNA(Lys) mutation and its complementation in MERRF patient-derived mitochondrial transformants.
Yoneda M; Miyatake T; Attardi G
Muscle Nerve Suppl; 1995; 3():S95-101. PubMed ID: 7603536
[TBL] [Abstract][Full Text] [Related]
2. Complementation and segregation behavior of disease-causing mitochondrial DNA mutations in cellular model systems.
Attardi G; Yoneda M; Chomyn A
Biochim Biophys Acta; 1995 May; 1271(1):241-8. PubMed ID: 7599215
[TBL] [Abstract][Full Text] [Related]
3. Complementation of mutant and wild-type human mitochondrial DNAs coexisting since the mutation event and lack of complementation of DNAs introduced separately into a cell within distinct organelles.
Yoneda M; Miyatake T; Attardi G
Mol Cell Biol; 1994 Apr; 14(4):2699-712. PubMed ID: 8139569
[TBL] [Abstract][Full Text] [Related]
4. Platelet-mediated transformation of mtDNA-less human cells: analysis of phenotypic variability among clones from normal individuals--and complementation behavior of the tRNALys mutation causing myoclonic epilepsy and ragged red fibers.
Chomyn A; Lai ST; Shakeley R; Bresolin N; Scarlato G; Attardi G
Am J Hum Genet; 1994 Jun; 54(6):966-74. PubMed ID: 8198140
[TBL] [Abstract][Full Text] [Related]
5. MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes.
Nakamura M; Yabe I; Sudo A; Hosoki K; Yaguchi H; Saitoh S; Sasaki H
J Med Genet; 2010 Oct; 47(10):659-64. PubMed ID: 20610441
[TBL] [Abstract][Full Text] [Related]
6. A MERRF/MELAS overlap syndrome associated with a new point mutation in the mitochondrial DNA tRNA(Lys) gene.
Zeviani M; Muntoni F; Savarese N; Serra G; Tiranti V; Carrara F; Mariotti C; DiDonato S
Eur J Hum Genet; 1993; 1(1):80-7. PubMed ID: 8069654
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of the COII/tRNA(Lys) intergenic 9-bp deletion in mitochondrial DNA of Taiwanese patients with MELAS or MERRF syndrome.
Liu CS; Cheng WL; Chen YY; Ma YS; Pang CY; Wei YH
Ann N Y Acad Sci; 2005 May; 1042():82-7. PubMed ID: 15965049
[TBL] [Abstract][Full Text] [Related]
8. Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease.
Yasukawa T; Suzuki T; Ishii N; Ohta S; Watanabe K
EMBO J; 2001 Sep; 20(17):4794-802. PubMed ID: 11532943
[TBL] [Abstract][Full Text] [Related]
9. Distribution and clinical expression of the tRNA(Lys) mutation in mitochondrial DNA in MERRF syndrome.
Huang CC; Chu NS; Shih KD; Pang CY; Wei YH
J Formos Med Assoc; 1995 Apr; 94(4):159-63. PubMed ID: 7606176
[TBL] [Abstract][Full Text] [Related]
10. Defect in modification at the anticodon wobble nucleotide of mitochondrial tRNA(Lys) with the MERRF encephalomyopathy pathogenic mutation.
Yasukawa T; Suzuki T; Ishii N; Ueda T; Ohta S; Watanabe K
FEBS Lett; 2000 Feb; 467(2-3):175-8. PubMed ID: 10675533
[TBL] [Abstract][Full Text] [Related]
11. Pathogenetic aspects of the A8344G mutation of mitochondrial DNA associated with MERRF syndrome and multiple symmetric lipomas.
Larsson NG; Tulinius MH; Holme E; Oldfors A
Muscle Nerve Suppl; 1995; 3():S102-6. PubMed ID: 7603509
[TBL] [Abstract][Full Text] [Related]
12. Point mutations in the mitochondrial tRNA(Lys) gene: implications for pathogenesis and mechanism.
Masucci JP; Schon EA; King MP
Mol Cell Biochem; 1997 Sep; 174(1-2):215-9. PubMed ID: 9309690
[TBL] [Abstract][Full Text] [Related]
13. Uniform tissue distribution of tRNA(Lys) mutation in mitochondrial DNA in MERRF patients.
Tanno Y; Yoneda M; Tanaka K; Kondo R; Hozumi I; Wakabayashi K; Yamada M; Fukuhara N; Ikuta F; Tsuji S
Neurology; 1993 Jun; 43(6):1198-200. PubMed ID: 8170566
[TBL] [Abstract][Full Text] [Related]
14. [MERRF/MELAS overlap syndrome].
Goto Y
Nihon Rinsho; 2002 Apr; 60 Suppl 4():296-7. PubMed ID: 12013869
[No Abstract] [Full Text] [Related]
15. [MERRF/MELAS overlap syndrome].
Goto Y
Ryoikibetsu Shokogun Shirizu; 2001; (36):159. PubMed ID: 11596353
[No Abstract] [Full Text] [Related]
16. Detection of known base substitution mutations in human mitochondrial DNA of MERRF and MELAS by biochip technology.
Du W; Li W; Chen G; Cao H; Tang H; Tang X; Jin Q; Sun Z; Zhao H; Zhou W; He S; Lv Y; Zhao J; Zhang X
Biosens Bioelectron; 2009 Apr; 24(8):2371-6. PubMed ID: 19155171
[TBL] [Abstract][Full Text] [Related]
17. Distribution and threshold expression of the tRNA(Lys) mutation in skeletal muscle of patients with myoclonic epilepsy and ragged-red fibers (MERRF).
Boulet L; Karpati G; Shoubridge EA
Am J Hum Genet; 1992 Dec; 51(6):1187-200. PubMed ID: 1334369
[TBL] [Abstract][Full Text] [Related]
18. [Molecular genetic analysis for myoclonus epilepsy associated with ragged-red fibers (MERRF)].
Tanno Y; Yoneda M; Tanaka K; Tsuji S
Nihon Rinsho; 1993 Sep; 51(9):2379-85. PubMed ID: 8411716
[TBL] [Abstract][Full Text] [Related]
19. MtDNA mutation in MERRF syndrome causes defective aminoacylation of tRNA(Lys) and premature translation termination.
Enriquez JA; Chomyn A; Attardi G
Nat Genet; 1995 May; 10(1):47-55. PubMed ID: 7647790
[TBL] [Abstract][Full Text] [Related]
20. Detection and quantification of point mutations in mitochondrial DNA by PCR.
Yoneda M; Tanno Y; Tsuji S; Attardi G
Methods Enzymol; 1996; 264():432-41. PubMed ID: 8965716
[No Abstract] [Full Text] [Related]
[Next] [New Search]
